aspartic acid has been researched along with Cancer of Larynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croft, W; Dyer, NP; Easton, AJ; Gould, PS; Ott, S | 1 |
| Briggle, TV; Greer, S; Mekras, JA; Perez, LM | 1 |
2 other study(ies) available for aspartic acid and Cancer of Larynx
| Article | Year |
|---|---|
Cellular mRNAs access second ORFs using a novel amino acid sequence-dependent coupled translation termination-reinitiation mechanism.
Topics: Algorithms; Aspartic Acid; Base Sequence; Blotting, Western; Calsequestrin; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Humans; Laryngeal Neoplasms; Molecular Sequence Data; Open Reading Frames; Peptide Chain Initiation, Translational; Peptide Chain Termination, Translational; RNA, Messenger; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured | 2014 |
Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
Topics: Animals; Aspartic Acid; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Radiation; Floxuridine; Humans; Laryngeal Neoplasms; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Tetrahydrouridine; Uridine | 1984 |